Login to Your Account

Analyst says Novan acne bid lives despite data mix

By Randy Osborne
Staff Writer

Friday, January 27, 2017

Novan Inc.'s effort to market the first-ever topical nitric oxide macromolecule stumbled on word that topical SB2014 met with success in one phase III trial but only a partial win in the second, identical study.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription